Human interleukin 1 induces interleukin i gene expression in human vascular smooth muscle cells

Journal of Experimental Medicine

Volumn 165, Issue 5, 1987, Pages 1316-1331

  Warner, Stephen J C ^a   Auger, Kurt R ^a   Libby, Peter ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DACTINOMYCIN; ESCHERICHIA COLI ENDOTOXIN; INDOMETACIN; INTERLEUKIN 1; MESSENGER RNA; POLYMYXIN B;

DRUG EFFICACY; GENE EXPRESSION; HEREDITY; HUMAN; HUMAN CELL; MUSCLE; NORMAL HUMAN; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMAN; INTERLEUKIN-1; MUSCLE, SMOOTH, VASCULAR; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0023179803     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.165.5.1316     Document Type: Article

References (53)

1. Bevilacqua, M. P., J. S. Pober, G. R. Majeau, R. S. Cotran, and M. A. Gimbrone, Jr. 1985. Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J. Clin. Invest. 76: 2003.
2. Cavender, D. E., D. O. Haskard, B. Joseph, and M. Ziff. 1986. Interleukin 1 increases the binding ofhuman B and T lymphocytes to endothelial cell monolayers.J. Immunol. 136: 203.
3. Pohlman, T. H., K. A. Stanness, P. G. Beatty, H. D. Ochs, and J. M. Harlan. 1986. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw 18- dependent mechanism.J. Immunol. 136: 4548.
4. Bevilacqua, M. P., J. S. Pober, G. R. Majeau, R. S. Cotran, and M. A. Gimbrone, Jr. 1984. Interleukin-I (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med. 160: 618.
5. Nachman, R. L., K. A. Hajjar, R. L. Silverstein, and C. A. Dinarello. 1986. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J. Exp. Med. 163: 1595.
6. Emeis, J. J., and T. Kooistra. 1986. Interleukin 1 and lipopolysaccharide induce an inhibitor oftissue-type plasminogen activator in vivo and in cultured endothelial cells. J. Exp. Med. 163: 1260.
7. Rossi, V., F. Breviario, P. Ghezzi, E. Dejana, and A. Mantovani. 1985. Prostacyclin synthesis induced in vascular cells by interleukin-1. Science (Wash. DC). 229: 174.
8. Albrightson, C. R., N. L. Baenziger, and P. Needleman. 1985. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J. Immunol. 135: 1872.
9. Dinarello, C. A. 1985. An update on human interleukin-1: from molecular biology to clinical relevance.J. Clin. Immunol. 5: 287.
10. March, C. J., B. Mosley, A. Larsen, D. P. Cerretti, G. Braedt, V. Price, S. Gillis, C. S. Henney, S. R. Kronheim, K. Grabstein, P. J. Conlon, T. P. Hopp, and D. Cosman. 1985. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (Loud.). 315: 641.
11. Libby, P., J. M. Ordovas, K. R. Auger, A. H. Robbins, L. K. Birinyi, and C. A. Dinarello. 1986. Endotoxi n and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124: 179.
12. Libby, P., J. M. Ordovas, L. K. Birinyi, K. R. Auger, and C. A. Dinarello. 1986. Inducibl e interleukin-1 expression in human vascular smooth muscle cells. J. Clin. Invest. 78: 1432.
13. Libby, P., J. M. Ordovas, and K. R. Auger. 1986. Tumor necrosis factor induces interleukin-1,β gene expression in human vascular smooth muscle. Circulation. 74: 11-157. (Abstr.)
14. Libby, P., and K. V. O’Brien. 1983. Culture of quiescent vascular smooth muscle cells in a defined serum-free medium. J. Cell. Physiol. 115: 217.
15. Ross, R., and Kariya, B. 1980. Morphogenesis of vascular smooth muscle in atherosclerosis and cell structure. Handb. Physiol. 2: 69.
16. Morrison, D. C., and L. Leive. 1975. Fractions of lipopolysaccharide from Escherichia coli 0111: B4 prepared by two extraction procedures. J. Biol. Chem. 250: 2911.
17. Warner, S. J. C., D. Mitchell, N. Savage, and E. McClain. 1985. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B. Biochem. Pharmacol. 34: 3995.
18. Dinarello, C. A., J. G. Cannon, J. W. Mier, H. A. Bernheim, G. LoPreste, D. L. Lynn, R. N. Love, A. C. Webb, P. E. Auron, R. C. Reuben, A. Rich, S. M. Wolff, and S. D. Putney. 1986. Multiple biological activities of human recombinant interleukin 1. J. Clin. Invest. 77: 1734.
19. Dinarello, C. A., L. Renfer, and S. M. Wolff. 1977. Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc. Natl. Acad. Sci. USA. 74: 4624.
20. Dinarello, C. A., L. Renfer, and S. M. Wolff. 1977. The production of antibody against human leukocytic pyrogen.J. Clin. Invest. 60: 465.
21. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino, Jr., and J. V. O’Connor. 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163: 1433.
22. Gubler, U., A. O. Chua, A. S. Stern, C. P. Hellman, M. P. Vitek, T. M. Dechiara, W. R. Benjamin, K. J. Collier, M. Dukovich, P. C. Familetti, C. Fiedler-Nagy, J. Jenson, K. Kaffka, P. L. Kilian, D. Stremlo, B. H. Wittreich, D. Woehle, S. B. Mizel, and P. T. Lomedico. 1986. Recombinant human interleukin la: purification and biological characterization. J. Immunol. 136: 2492.
23. Todd, R. F. III, L. M. Nadler, and S. F. Schlossman. 1981. Antigen s on human monocytes identified by monoclonal antibodies.J. Immunol. 126: 1435.
24. Todd, R. F. III, E. L. Leeman, J. F. Daley, and S. F. Schlossman. 1983. Mot: functional properties of antigen-bearing cells. Clin. Immunol. Immunopathol. 26: 118.
25. Chirgwin, J. M., A. E. Pryzbyla, R. J. Macdonald, and W. J. Rutter. 1979. Isolatio n of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18: 5294.
26. Glisin, V., R. Crkvenjakov, and C. Byus. 1974. Ribonucleic acid isolation by cesium chloride centrifugation. Biochemistry. 13: 2633.
27. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY. 545 pp.
28. Auron, P. E., A. C. Webb, L. J. Rosenwasser, S. F. Mucci, A. Rich, S. M. Wolff, and C. A. Dinarello. 1984. Nucleotide sequence of human monocyte interleukin-1 precursor cDNA. Proc. Natl. Acad. Sci. USA. 81: 7907.
29. Bond, J. F., and S. R. Farmer. 1983. Regulation of tubulin and actin mRNA production in rat brain: expression of a new beta-tubulin mRNA with development. Mol. Cell. Biol. 3: 1333.
30. Bywater, M., R. Bywater, and L. Hellman. 1983. A novel chromatographic procedure for purification of bacterial plasmids. Anal. Biochem. 132: 219.
31. Rosenwasser, L. J., and C. A. Dinarello. 1981. Ability of human leukocytic pyrogen to enhance phytohemagglutinin-induced murine thymocyte proliferation. Cell. Immunol. 63: 134.
32. Miossec, P., D. Cavender, and M. Ziff. 1986. Production of interleukin-1 by human endothelial cells. J. Immunol. 136: 2486.
33. Goodwin, J. S., and D. R. Webb. 1980. Regulatio n of the immune response by prostaglandins. Clin. Immunol. Immunopathol. 15: 106.
34. Lepe-Zuniga, J. L., and I. Gery. 1984. Production of intra- and extracellular interleukin-1 (IL-1) by human monocytes. Clin. Immunol. Immunopathol. 31: 222.
35. Morrison, D. C., and R. J. Ulevitch. 1978. The effects of bacterial endotoxins on host mediation systems. Am. J. Pathol. 93: 527.
36. Kluger, M. J., R. Singer, and S. M. Eiger. 1985. Polymyxin B use does not ensure endotoxin-free solution. J. Immunol. Methods. 83: 201.
37. Pober, J. S., M. A. Gimbrone, Jr., R. S. Cotran, C. S. Reiss, S. J. Burakoff, W. Fiers, and K. A. Ault. 1983. Ia expression by vascular endothelium is inducible by activated T cells and by human γ interferon. J. Exp. Med. 157: 1339.
38. Montesano, R., L. Orci, and P. Vassalli. 1984. Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins. J. Cell. Physiol. 122: 424.
39. Bussolino, F., F. Breviario, C. Tetta, M. Aglietta, A. Mantovani, and E. Dejana. 1986. Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J. Clin. Invest. 77: 2027.
40. Jonasson, L., J. Holm, O. Skalli, G. Bondjers, and G. K. Hansson. 1986. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6: 131.
41. Gown, A. M., T. Tsukuda, and R. Ross. 1986. Human atherosclerosis. 11. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125: 191.
42. Jonasson, L., J. Holm, O. Skalli, G. Gabbiani, and G. K. Hansson. 1985. Expression of class 11 transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Invest. 76: 125.
43. Gerrity, R. G. 1981. The role of the monocyte in atherogenesis. 1. Transition of blood-borne monocytes into foam cells. Am. J. Pathol. 103: 181.
44. Faggioto, A., R. Ross, and L. Harker. 1984. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis. 4: 323.
45. Faggioto, A., and R. Ross. 1984. Studies of hypercholesterolemia in the nonhuman primate. 11. Fatty streak conversion to fibrous plaque. Arteriosclerosis. 4: 341.
46. Jauchem, J. R. 1986. Leukocyte chemotactic factors from vascular smooth muscle cells. Comp. Biochem. Physiol. 83A: 603.
47. Berliner, J. A., M. Territo, L. Almada, A. Carter, E. Shafonsky, and A. M. Fogelman. 1986. Monocyte chemotactic factor produced by large vessel endothelial cells in vitro. Arteriosclerosis. 6: 254.
48. Oppenheim, J. J. 1985. Antigen nonspecific lymphokines: an overview. Methods Enzymol. 116: 357.
49. Pober, J. S., T. Collins, M. A. Gimbrone, Jr., P. Libby, and C. S. Reiss. 1986. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation (Baltimore). 41: 141.
50. Hajjar, D. 1985. Prostaglandins and cyclic nucleotides: modulators of arterial cholesterol metabolism. Biochem. Pharmacol. 34: 295.
51. Moyer, C. F., and C. L. Reinisch. 1984. The role of vascular smooth muscle cells in experimental autoimmune vasculitis. 1. The initiation of delayed type hypersensitivity angiitis. Am. J. Pathol. 117: 380.
52. Pober, J. S., M. P. Bevilacqua, D. L. Mendrick, L. A. Lapierre, W. Fiers, and M. A. Gimbrone, Jr. 1986. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 136: 1680.
53. Cotran, R. S., M. A. Gimbrone, Jr., M. P. Bevilacqua, D. L. Mendrick, and J. S. Pober. 1986. Induction and detection of a human endothelial activation antigen in vivo. J. Exp. Med. 164: 661.